课题基金 / 基金详情

A Pilot Randomized-Controlled Trial of Lipoprotein(a) Lowering for the Prevention of Aortic Valve Disease - Translating genomic knowledge for cardiovascular prevention.

A Pilot Randomized-Controlled Trial of Lipoprotein(a) Lowering for the Prevention of Aortic Valve Disease - Translating genomic knowledge for cardiovascular prevention.
降低脂蛋白（a）预防主动脉瓣疾病的随机对照试验 - 将基因组知识转化为心血管预防。
批准号：
267883
负责人：
Thanassoulis George
金额：
$50.41万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-09-01 至 2017-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=267883&lang=en
关键词：
Aortic Stenosis Calcification Genomics Lipoprotein (A) Personalized Medicine Prevention Randomized-Controlled Trial

项目摘要

项目成果

Thanassoulis George的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aortic valve disease is the most common form of heart valve disease and is a major burden to society. Aortic valve disease is also expected to become more prevalent with the aging of the Canadian population. Currently, over 1 million individuals in North
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomics of Aortic Stenosis - An International Collaboration
Addressing knowledge gaps in the use of lipoprotein testing in cardiovascular prevention
Genomics of Aortic Stenosis - an International Collaboration
Genomics of Aortic Stenosis - an International Collaboration
海外基金